featured
Impact of Adalimumab Therapy in Patients With Active, Non-Infectious Intermediate, Posterior, or Panuveitis in Clinical Practice
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The British Journal of Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of adalimumab in patients with active non-infectious intermediate, posterior, and panuveitis in real-life clinical practice: HOPE study
Br J Ophthalmol 2023 Nov 22;107(12)1892-1899, U Pleyer, S Al-Mutairi, CC Murphy, R Hamam, S Hammad, O Nagy, Z Szepessy, Y Guex-Crosier, K Julian, Z Habot-Wilner, S AndroudiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.